China Resources Pharmaceutical Group Limited (HKG: 3320)

China Resources Pharmaceutical Group Revenue

China Resources Pharmaceutical Group had revenue of 64.30B CNY in the quarter ending June 30, 2024, with 4.71% growth. This brings the company's revenue in the last twelve months to 250.48B, up 11.50% year-over-year. In the year 2023, China Resources Pharmaceutical Group had annual revenue of 244.70B with 12.16% growth.

• Revenue (ttm): 250.48B CNY
• Revenue Growth: +11.50%
• P/S Ratio: 0.14
• Revenue / Employee: 3.43M CNY
• Employees: 72,986
• Market Cap: 37.44B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	244.70B	26.52B	12.16%
Dec 31, 2022	218.18B	-18.62B	-7.86%
Dec 31, 2021	236.81B	36.38B	18.15%
Dec 31, 2020	200.42B	-4.03B	-1.97%
Dec 31, 2019	204.45B	14.76B	7.78%